aMoon

aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.

Author: gaby hirsch

Guardant buys MetaSight for $59M upfront to acquire blood test tech

Posted on March 15, 2026March 15, 2026Author gaby hirschCategories News
Contact Careers terms of service privacy policy
aMoon on linkedin aMoon on linkedin aMoon on twitter aMoon on twitter aMoon on youtube aMoon on youtube
Ra'anana, Israel
© aMoon Website by nym. Developed by Rabbi Interactive